RNAi for Therapeutic Market - Global Outlook and Forecast 2021-2027

Code: RW00014503555
Market Monitor Global
Sep-2021
Life Sciences
107 Pages

This report contains market size and forecasts of RNAi for Therapeutic in Global, including the following market information:
Global RNAi for Therapeutic Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global RNAi for Therapeutic market was valued at 1956.3 million in 2020 and is projected to reach US$ 4349.1 million by 2027, at a CAGR of 22.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNAi for Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNAi for Therapeutic Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global RNAi for Therapeutic Market Segment Percentages, By Type, 2020 (%)
siRNA
miRNA
shRNA

China RNAi for Therapeutic Market, By Application, 2016-2021, 2022-2027 ($ millions)
China RNAi for Therapeutic Market Segment Percentages, By Application, 2020 (%)
Cancer
Cardiovascular
HBV
Others

Global RNAi for Therapeutic Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global RNAi for Therapeutic Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total RNAi for Therapeutic Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total RNAi for Therapeutic Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 RNAi for Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNAi for Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNAi for Therapeutic Overall Market Size
2.1 Global RNAi for Therapeutic Market Size: 2021 VS 2027
2.2 Global RNAi for Therapeutic Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNAi for Therapeutic Players in Global Market
3.2 Top Global RNAi for Therapeutic Companies Ranked by Revenue
3.3 Global RNAi for Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 RNAi for Therapeutic Companies in Global Market, by Revenue in 2020
3.5 Global Companies RNAi for Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNAi for Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 RNAi for Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 RNAi for Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNAi for Therapeutic Market Size Markets, 2021 & 2027
4.1.2 siRNA
4.1.3 miRNA
4.1.4 shRNA
4.2 By Type - Global RNAi for Therapeutic Revenue & Forecasts
4.2.1 By Type - Global RNAi for Therapeutic Revenue, 2016-2021
4.2.2 By Type - Global RNAi for Therapeutic Revenue, 2022-2027
4.2.3 By Type - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNAi for Therapeutic Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Cardiovascular
5.1.4 HBV
5.1.5 Others
5.2 By Application - Global RNAi for Therapeutic Revenue & Forecasts
5.2.1 By Application - Global RNAi for Therapeutic Revenue, 2016-2021
5.2.2 By Application - Global RNAi for Therapeutic Revenue, 2022-2027
5.2.3 By Application - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global RNAi for Therapeutic Market Size, 2021 & 2027
6.2 By Region - Global RNAi for Therapeutic Revenue & Forecasts
6.2.1 By Region - Global RNAi for Therapeutic Revenue, 2016-2021
6.2.2 By Region - Global RNAi for Therapeutic Revenue, 2022-2027
6.2.3 By Region - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America RNAi for Therapeutic Revenue, 2016-2027
6.3.2 US RNAi for Therapeutic Market Size, 2016-2027
6.3.3 Canada RNAi for Therapeutic Market Size, 2016-2027
6.3.4 Mexico RNAi for Therapeutic Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe RNAi for Therapeutic Revenue, 2016-2027
6.4.2 Germany RNAi for Therapeutic Market Size, 2016-2027
6.4.3 France RNAi for Therapeutic Market Size, 2016-2027
6.4.4 U.K. RNAi for Therapeutic Market Size, 2016-2027
6.4.5 Italy RNAi for Therapeutic Market Size, 2016-2027
6.4.6 Russia RNAi for Therapeutic Market Size, 2016-2027
6.4.7 Nordic Countries RNAi for Therapeutic Market Size, 2016-2027
6.4.8 Benelux RNAi for Therapeutic Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia RNAi for Therapeutic Revenue, 2016-2027
6.5.2 China RNAi for Therapeutic Market Size, 2016-2027
6.5.3 Japan RNAi for Therapeutic Market Size, 2016-2027
6.5.4 South Korea RNAi for Therapeutic Market Size, 2016-2027
6.5.5 Southeast Asia RNAi for Therapeutic Market Size, 2016-2027
6.5.6 India RNAi for Therapeutic Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America RNAi for Therapeutic Revenue, 2016-2027
6.6.2 Brazil RNAi for Therapeutic Market Size, 2016-2027
6.6.3 Argentina RNAi for Therapeutic Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNAi for Therapeutic Revenue, 2016-2027
6.7.2 Turkey RNAi for Therapeutic Market Size, 2016-2027
6.7.3 Israel RNAi for Therapeutic Market Size, 2016-2027
6.7.4 Saudi Arabia RNAi for Therapeutic Market Size, 2016-2027
6.7.5 UAE RNAi for Therapeutic Market Size, 2016-2027
7 Players Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Corporate Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.1.4 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue in Global (2016-2021)
7.1.5 Alnylam Pharmaceuticals Key News
7.2 Arbutus Biopharma (Tekmira)
7.2.1 Arbutus Biopharma (Tekmira) Corporate Summary
7.2.2 Arbutus Biopharma (Tekmira) Business Overview
7.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Major Product Offerings
7.2.4 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue in Global (2016-2021)
7.2.5 Arbutus Biopharma (Tekmira) Key News
7.3 Arrowhead
7.3.1 Arrowhead Corporate Summary
7.3.2 Arrowhead Business Overview
7.3.3 Arrowhead RNAi for Therapeutic Major Product Offerings
7.3.4 Arrowhead RNAi for Therapeutic Revenue in Global (2016-2021)
7.3.5 Arrowhead Key News
7.4 Dicerna Pharmaceuticals
7.4.1 Dicerna Pharmaceuticals Corporate Summary
7.4.2 Dicerna Pharmaceuticals Business Overview
7.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.4.4 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue in Global (2016-2021)
7.4.5 Dicerna Pharmaceuticals Key News
7.5 Mirna Therapeutics
7.5.1 Mirna Therapeutics Corporate Summary
7.5.2 Mirna Therapeutics Business Overview
7.5.3 Mirna Therapeutics RNAi for Therapeutic Major Product Offerings
7.5.4 Mirna Therapeutics RNAi for Therapeutic Revenue in Global (2016-2021)
7.5.5 Mirna Therapeutics Key News
7.6 Quark Pharmaceuticals
7.6.1 Quark Pharmaceuticals Corporate Summary
7.6.2 Quark Pharmaceuticals Business Overview
7.6.3 Quark Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.6.4 Quark Pharmaceuticals RNAi for Therapeutic Revenue in Global (2016-2021)
7.6.5 Quark Pharmaceuticals Key News
7.7 RXi Pharmaceuticals
7.7.1 RXi Pharmaceuticals Corporate Summary
7.7.2 RXi Pharmaceuticals Business Overview
7.7.3 RXi Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.4.4 RXi Pharmaceuticals RNAi for Therapeutic Revenue in Global (2016-2021)
7.7.5 RXi Pharmaceuticals Key News
7.8 Silence Therapeutics
7.8.1 Silence Therapeutics Corporate Summary
7.8.2 Silence Therapeutics Business Overview
7.8.3 Silence Therapeutics RNAi for Therapeutic Major Product Offerings
7.8.4 Silence Therapeutics RNAi for Therapeutic Revenue in Global (2016-2021)
7.8.5 Silence Therapeutics Key News
7.9 Benitec Biopharma
7.9.1 Benitec Biopharma Corporate Summary
7.9.2 Benitec Biopharma Business Overview
7.9.3 Benitec Biopharma RNAi for Therapeutic Major Product Offerings
7.9.4 Benitec Biopharma RNAi for Therapeutic Revenue in Global (2016-2021)
7.9.5 Benitec Biopharma Key News
7.10 miRagen Therapeutics
7.10.1 miRagen Therapeutics Corporate Summary
7.10.2 miRagen Therapeutics Business Overview
7.10.3 miRagen Therapeutics RNAi for Therapeutic Major Product Offerings
7.10.4 miRagen Therapeutics RNAi for Therapeutic Revenue in Global (2016-2021)
7.10.5 miRagen Therapeutics Key News
7.11 Sylentis
7.11.1 Sylentis Corporate Summary
7.11.2 Sylentis Business Overview
7.11.3 Sylentis RNAi for Therapeutic Major Product Offerings
7.11.4 Sylentis RNAi for Therapeutic Revenue in Global (2016-2021)
7.11.5 Sylentis Key News
7.12 Gradalis
7.12.1 Gradalis Corporate Summary
7.12.2 Gradalis Business Overview
7.12.3 Gradalis RNAi for Therapeutic Major Product Offerings
7.12.4 Gradalis RNAi for Therapeutic Revenue in Global (2016-2021)
7.12.5 Gradalis Key News
7.13 Sirnaomics
7.13.1 Sirnaomics Corporate Summary
7.13.2 Sirnaomics Business Overview
7.13.3 Sirnaomics RNAi for Therapeutic Major Product Offerings
7.13.4 Sirnaomics RNAi for Therapeutic Revenue in Global (2016-2021)
7.13.5 Sirnaomics Key News
7.14 Silenseed
7.14.1 Silenseed Corporate Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNAi for Therapeutic Major Product Offerings
7.14.4 Silenseed RNAi for Therapeutic Revenue in Global (2016-2021)
7.14.5 Silenseed Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. RNAi for Therapeutic Market Opportunities & Trends in Global Market
Table 2. RNAi for Therapeutic Market Drivers in Global Market
Table 3. RNAi for Therapeutic Market Restraints in Global Market
Table 4. Key Players of RNAi for Therapeutic in Global Market
Table 5. Top RNAi for Therapeutic Players in Global Market, Ranking by Revenue (2019)
Table 6. Global RNAi for Therapeutic Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global RNAi for Therapeutic Revenue Share by Companies, 2016-2021
Table 8. Global Companies RNAi for Therapeutic Product Type
Table 9. List of Global Tier 1 RNAi for Therapeutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNAi for Therapeutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE